P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay by Haynes BF, Moody MA, Vandergrift N, Hwang K, Bonsignori M

V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site by McLellan JS, Gorman J, Bonsignori M, Hwang K, Liao H, Rerks-Ngarm S, Nitayaphan S, Michael NL, Kim JH, Haynes BF, Kwong PD

Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay by Rao M, Karasavvas N, Pinter A, Liao H, Bonsignori M, Mathieson B, Zolla-Pazner S, Haynes BF, Michael NL, Kim JH, Alving CR, Peachman KK

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth by Roskin, KM, Jackson, KJL, Lee, JY, Hoh, RA, Joshi, SA, Hwang, KK, Bonsignori, M, Pedroza-Pacheco, I, Liao, HX, Moody, MA, Fire, AZ, Borrow, P, Haynes, BF, Boyd, SD

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies by Doria-Rose NA, Georgiev I, Staupe RP, O'Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family by Bonsignori M, Pollara J, Moody MA, Kepler TB, Chen X, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim JH, Michael NL, Montefiori DC, Liao H, Ferrari G, Haynes BF

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes by Pollara J, Bonsignori M, Moody M, Alam M, Liao H, Hwang K, Pickeral J, Kappes J, Ochsenbauer C, Soderberg K, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Montefiori D, Robinson JE, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim J, Michael N, Tomaras G, Haynes BF, Ferrari G

Antibody lineages with evidence of somatic hypermutation persisting for >4 years in a South African subject with broad neutralizing activity by Moody M, Trama AM, Bonsignori M, Tsao C, Drinker MS, Gurley TC, Amos JD, Eudailey JA, Armand LC, Parks R, Lloyd KE, Wang S, Seo K, Lee J, Jackson KJ, Hoh R, Pham T, Roskin KM, Boyd SD, Fire AZ, Gray ES, Morris L, Liao H, Tomaras GD, Kepler TB, Kelsoe G, Haynes BF

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies by LaBranche, C, Henderson, R, Hsu, A, Behrens, S, Chen, X, Zhou, T, Wiehe, K, Saunders, KO, Alam, SM, Bonsignori, M, Borgnia, MJ, Sattentau, QJ, Eaton, A, Greene, K, Gao, H, Liao, HX, Williams, WB, Peacock, J, Tang, H, Perez, LG, Edwards, RJ, Kepler, TB, Korber, BT, Kwong, PD, Mascola, JR, Acharya, P, Haynes, BF, Montefiori, DC

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2 by Liao L, Bonsignori M, Hwang K, Moody AM, Park R, Crawford S, Chen H, Jeffries TL, Cooper M, Lu X, De R, Karasavvas N, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Tovanabutra S, Pitisuttithum P, Tartaglia J, Sinangil F, Kim J, Michael NL, Tomaras GD, Yang Z, Dai K, Pancera M, Nabel GJ, Mascola JR, Kwong PD, Pinter A, Zolla-Pazner S, Alam MS, Haynes BF